The global monoclonal antibody therapy market is gaining momentum, reaching a valuation of USD 230.87 billion in 2023. With a projected CAGR of 14.8% from 2024 to 2032, this sector is poised for significant growth, potentially hitting USD 792.37 billion by 2032. The opportunities in this thriving industry are immense!
For more insights, access your free sample PDF here: https://www.fortunebusinessinsights.com/monoclonal-antibody-therapy-market-102734